Clinicians should monitor for red flags requiring higher levels of care, including suicidal ideation, severe depression, medical instability, significant electrolyte disturbances, or severe dehydration
June 2026 update: FDA issues 25 more warning letters to telehealth companies During the week of June 15, 2026 - days before this article was published - the FDA issued 25 additional warning letters to telehealth companies over false or misleading promotional claims about compounded GLP-1 products
If you notice persistent redness, swelling, or pain, contact your provider promptly
This is a common and important questionespecially for those considering or currently undergoing testosterone replacement therapy
Occasional mild symptoms may occur, but the constant nausea and digestive disruption of earlier weeks fades